我要投票 腾药在乌鸡白凤丸行业中的票数:553
· 外 推 电 报 ·
2025-08-14 09:44:25 星期四

【腾药是哪个国家的品牌?】

腾药是什么牌子?「腾药」是 云南腾药制药股份有限公司 旗下著名品牌。该品牌发源于云南,由创始人赵丙贤在1990-06-22期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力腾药品牌出海!将品牌入驻外推网,定制腾药品牌推广信息,可以显著提高腾药产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

腾冲,西南极边第一城,地处中缅边境,是中国古代南丝绸之路的必经之道。这里除了世人皆知的火山热海的奇特自然景观外,得天独厚的生物资源优势,也使之成为发展医药事业的天赐宝地。腾药历史,源远流长,早在北宋年间就有所记载,距今已有800多年。经历代药物学者和名医精研提炼,形成了其优良的品质和独特的风格。

云南省腾冲制药厂创建于上世纪五十年代,至今已有半个世纪的历史,而作为腾冲制药厂的发祥地,为纪念医药先贤“药王”孙思邈而修建的祠堂——“药王宫”则已有370多年的历史。这里荟萃了当地历史上不同流派的著名药店和医家精华,经过几代人的奋斗,早在上世纪七十年代就已步入全国重点中成药厂行列,在云南150多家医药工业企业中具有举足轻重的地位。尤其在产业结构、产品市场份额、专业技术力量、职工队伍素质等方面优势明显,被国家中医药管理局评为全国中药行业“优秀企业”金奖单位,连年被云南省政府评为“省级文明单位”和“先进管理企业”。目前生产的主要剂型有丸剂、冲剂、片剂、酊剂、散剂、糖浆剂、酒剂等七大剂型108个品种,年生产量达千吨以上,产品遍及省内外及东南亚地区,并享有良好的声誉。其中人参再造丸、大活络丸、六味地黄丸、感冒疏风片、藿香正气水等被列为云南省名优产品。

为追求领先的产品质量,改进管理水平,提升和打造“腾药”品牌,2002年下半年,药厂投资3500万元兴建现代化的GMP厂房,引进国际先进的制药机械更新生产线。目前,GMP厂房拥有七条现代化生产线,效率提高了3-4倍,并于2003年11月顺利通过了GMP认证。

为适应现代企业的要求,追求更高更快的发展,跨入新世纪,腾冲制药厂在现代企业制度的指导下,将走规模化和集团化的道路,促进新产品的开发和引进,充分发挥云南天然植物药的特色和优势,为云南医药产业的腾飞作出积极贡献!

英文翻译:Tengchong, the first city on the southwest pole, is located at the border between China and Myanmar, which is the only way along the ancient Southern Silk Road of China. In addition to the world's well-known unique natural landscape, the unique advantages of biological resources also make it a heaven-given treasure for the development of medicine. It has a long history. It was recorded as early as the Northern Song Dynasty. It has been more than 800 years since then. Through the refined research and refinement of modern medicine scholars and famous doctors, it has formed its excellent quality and unique style. Yunnan Tengchong pharmaceutical factory, founded in the 1950s, has a history of half a century. As the birthplace of Tengchong pharmaceutical factory, the ancestral hall "Yaowang Palace" built to commemorate Sun Simiao, the medicine sage, has a history of more than 370 years. It has gathered the essence of famous pharmacies and doctors in different schools in the local history. After several generations of struggle, it has entered the ranks of key Chinese patent medicine factories in the 70s of last century. It has a pivotal position in more than 150 pharmaceutical industrial enterprises in Yunnan. In particular, it has obvious advantages in industrial structure, product market share, professional and technical strength, staff quality, etc. it has been awarded the gold medal unit of "excellent enterprise" in the national traditional Chinese medicine industry by the State Administration of traditional Chinese medicine, and the "provincial civilized unit" and "advanced management enterprise" by the Yunnan provincial government for successive years. At present, there are 108 kinds of seven dosage forms, including pill, granule, tablet, tincture, powder, syrup, liquor, etc., with annual production of more than 1000 tons. The products are all over the province and Southeast Asia, and enjoy a good reputation. Among them, Renshen Zaizai Wan, Dahuoluo Wan, Liuwei Dihuang Wan, Ganmao Shufeng tablet, Huoxiang Zhengqi water are listed as famous and excellent products in Yunnan Province. In order to pursue the leading product quality, improve the management level, enhance and create the "tengyao" brand, in the second half of 2002, the pharmaceutical factory invested 35 million yuan to build a modern GMP plant, and introduced the international advanced pharmaceutical machinery to update the production line. At present, GMP plant has seven modern production lines, the efficiency has increased 3-4 times, and passed GMP certification in November 2003. In order to meet the requirements of modern enterprises, pursue higher and faster development, and stride into the new century, under the guidance of modern enterprise system, Tengchong pharmaceutical factory will take the road of scale and collectivization, promote the development and introduction of new products, give full play to the characteristics and advantages of Yunnan natural plant medicine, and make positive contributions to the take-off of Yunnan pharmaceutical industry!

本文链接: https://www.waitui.com/brand/10f3ee07f.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

沪指突破拉动公募赚钱效应,股基增量资金加速入市

公募机构的做多热情与赚钱效应,正通过指数突破行情得到直观印证。8月13日,沪指一举突破2024年10月8日创下的情绪高点3674.40点,并同步刷新2021年12月以来的指数新高。在指数突破的当日,公募基金产品的业绩表现呈现出显著的赚钱效应扩散特征——年内各类主题基金多点开花,高收益产品层出不穷,一举扭转了过去单一行业基金“独领风骚”的结构性行情特征。这一变化进一步推动股票型基金成为公募发行的核心品种,场外资金借道权益类产品加速涌入市场,既为资本市场注入增量流动性,又形成“行情—赚钱效应—资金流入”的正向循环,为股票市场的持续走强提供了有力支撑。(证券时报)

2小时前

公募基金费率改革不断提速,第二批浮动费率基金发行节奏显著快于预期

近日,记者从渠道获悉,中欧核心智选混合基金因募集规模突破20亿元提前结束发行,易方达价值回报混合同样宣布提前结束募集,第二批浮动费率基金发行节奏显著快于预期。近年来,公募基金费率改革不断提速。自证监会今年5月发布《推动公募基金高质量发展行动方案》以来,浮动费率机制被视为行业重点试点方向。此次中欧核心智选、易方达价值回报混合的提前结募,反映出该类产品正获得市场快速认可。(证券时报)

2小时前

印度Infosys公司将以1.53亿美元收购澳洲电信子公司75%的股份

印度IT服务公司印孚瑟斯(Infosys)周三表示,将以2.333亿澳元(约合1.53亿美元)收购澳大利亚电信集团(Telstra Group)旗下全资子公司Versent集团75%的股份。印孚瑟斯在一份声明中称,Versent集团为澳大利亚金融、能源、公用事业、政府和教育等行业的机构提供云服务。该交易预计将于 2026 财年下半年完成,但需获得澳大利亚外国投资审查委员会以及澳大利亚竞争与消费者委员会的批准。(新浪财经)

2小时前

以实际行动传递乐观情绪,公募频繁自购

公募自购热情不断升温,指数基金成为重要标的。近日,南方基金公告称,将以不少于2.3亿元的资金自购旗下多只权益类ETF。数据显示,今年以来公募自购权益类基金的净申购总额已经超过27亿元。业内人士认为,公募的自购行为,既能与基民利益绑定、为市场注入增量资金,也传递出对中国经济复苏动能的信心,以及对市场中长期趋势的乐观预判。(上证报)

2小时前

华泰证券:政策预期向好,把握银行结构性机会

36氪获悉,华泰证券指出,8月12日,财政部、央行、金融监管总局印发《个人消费贷款财政贴息政策实施方案》,年贴息比例为1%,中央财政、省级财政分别承担贴息资金的90%、10%,政府出资替代银行单边让利,有助于呵护息差,撬动信贷投放。7月31日国常会部署实施个人消费贷款贴息政策与服务业经营主体贷款贴息政策,8月以来工行、农行、建行、交行等多家银行积极响应个人消费贷款贴息政策与服务业经营主体贷款贴息政策。政策预期向好,把握银行结构性机会。

2小时前

本页详细列出关于腾药的品牌信息,含品牌所属公司介绍,腾药所处行业的品牌地位及优势。
咨询